Clinical trials
Terminated Lymphoma, Large B-Cell, Diffuse trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Masonic Cancer Center, University of Minnesota | 2 |
| Astex Pharmaceuticals, Inc. | 1 |
| Case Comprehensive Cancer Center | 1 |
| City of Hope Medical Center | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Fred Hutchinson Cancer Center | 1 |
| M.D. Anderson Cancer Center | 1 |
| OHSU Knight Cancer Institute | 1 |
| Pack Health | 1 |
| Rutgers, The State University of New Jersey | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Large B-Cell, Diffuse | 15 |
| Lymphoma, Mantle-Cell | 13 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 13 |
| Burkitt Lymphoma | 12 |
| Hodgkin Disease | 12 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 12 |
| Lymphoma, B-Cell, Marginal Zone | 12 |
| Lymphoma, Follicular | 12 |
| Lymphoma, Non-Hodgkin | 12 |
| Lymphoma, Large-Cell, Immunoblastic | 11 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.